Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,860 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer.
Wang H, Yao Z, Kang K, Zhou L, Xiu W, Sun J, Xie C, Yu M, Li Y, Zhang Y, Zheng Y, Lin G, Pan X, Wu Y, Luo R, Wang L, Tang M, Liao S, Zhu J, Zhou X, Zhang X, Xu Y, Liu Y, Peng F, Wang J, Xiang L, Yin L, Deng L, Huang M, Gong Y, Zou B, Wang H, Wu L, Yuan Z, Bi N, Fan M, Xu Y, Tong R, Yi L, Gan L, Xue J, Mo X, Chen C, Na F, Lu Y. Wang H, et al. Among authors: yuan z. Med. 2024 Oct 11;5(10):1237-1254.e9. doi: 10.1016/j.medj.2024.06.002. Epub 2024 Jul 3. Med. 2024. PMID: 38964333 Free article. Clinical Trial.
Pericytes: a double-edged sword in cancer therapy.
Meng MB, Zaorsky NG, Deng L, Wang HH, Chao J, Zhao LJ, Yuan ZY, Ping W. Meng MB, et al. Future Oncol. 2015;11(1):169-79. doi: 10.2217/fon.14.123. Future Oncol. 2015. PMID: 25143028 Review.
Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer.
Wang HH, Deng L, Wen QL, Zhang CZ, Zaorsky NG, Zhang BL, Chen J, Zeng XL, Cui YL, Shi YY, Hou HL, Wang W, Jiang B, Wang J, Pang QS, Zhao LJ, Yuan ZY, Wang P, Meng MB. Wang HH, et al. Oncotarget. 2017 May 23;8(38):62998-63013. doi: 10.18632/oncotarget.18071. eCollection 2017 Sep 8. Oncotarget. 2017. PMID: 28968966 Free PMC article.
[Combination of Radiation Therapy and Immunotherapy for Non-small Cell Lung Cancer: Peer Exchange on Frontier Academic Topics].
Radiotherapy-Immunotherapy Discussion Group; Ai X, Cai Y, Chu Q, Han C, Lu Y, Qin S, Wu L, Xie C, Yuan Z, Zhong W, Zhu X, Chang JY, Zhu Z. Radiotherapy-Immunotherapy Discussion Group, et al. Among authors: yuan z. Zhongguo Fei Ai Za Zhi. 2020 Jun 20;23(6):532-540. doi: 10.3779/j.issn.1009-3419.2020.102.24. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32517461 Free PMC article. Review. Chinese.
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial.
Xing L, Wu G, Wang L, Li J, Wang J, Yuan Z, Chen M, Xu Y, Fu X, Zhu Z, Lu Y, Han C, Xia T, Xie C, Li G, Ma S, Lu B, Lin Q, Zhu G, Qu B, Zhu W, Yu J. Xing L, et al. Among authors: yuan z. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1349-1358. doi: 10.1016/j.ijrobp.2020.11.026. Epub 2020 Nov 19. Int J Radiat Oncol Biol Phys. 2021. PMID: 33220395 Clinical Trial.
10,860 results
You have reached the last available page of results. Please see the User Guide for more information.